Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT06175780 · UNKNOWN

Trial details

NCT number: NCT06175780
Sponsor: Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Neoplasms by Histologic Type

Start date: 2022-12-28
Primary completion: 2025-12-28
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.